Oct. 25 at 2:29 PM
$CELZ đ CELZ is making waves in cell therapy!
With their ImmCelz⢠T-reg platform, iPSC-derived cells, and AlloStem⢠allogene therapies, CELZ is tackling regenerative medicine and immune modulation like few others. Clinical trials in diabetes and chronic pain are already underway, and their innovative approach sets them apart from traditional oncology-focused cell therapy companies. đ
If clinical results continue to shine, CELZ has the potential to become a global leader in next-gen cell therapies. Watch this space! đĄ